Literature DB >> 25303934

Crosstalk between Mycobacterium tuberculosis and the host cell.

Bappaditya Dey1, William R Bishai2.   

Abstract

The successful establishment and maintenance of a bacterial infection depend on the pathogen's ability to subvert the host cell's defense response and successfully survive, proliferate, or persist within the infected cell. To circumvent host defense systems, bacterial pathogens produce a variety of virulence factors that potentiate bacterial adherence and invasion and usurp host cell signaling cascades that regulate intracellular microbial survival and trafficking. Mycobacterium tuberculosis, probably one of the most successful pathogens on earth, has coexisted with humanity for centuries, and this intimate and persistent connection between these two organisms suggests that the pathogen has evolved extensive mechanisms to evade the human immune system at multiple levels. While some of these mechanisms are mediated by factors released by M. tuberculosis, others rely on host components that are hijacked to prevent the generation of an effective immune response thus benefiting the survival of M. tuberculosis within the host cell. Here, we describe several of these mechanisms, with an emphasis on the cyclic nucleotide signaling and subversion of host responses that occur at the intracellular level when tubercle bacilli encounter macrophages, a cell that becomes a safe-house for M. tuberculosis although it is specialized to kill most microbes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cyclic AMP; Cyclic di-AMP; Immunity; Interferon; Macrophage; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25303934      PMCID: PMC4250340          DOI: 10.1016/j.smim.2014.09.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  172 in total

Review 1.  cAMP-PKA signaling to the mitochondria: protein scaffolds, mRNA and phosphatases.

Authors:  Antonio Feliciello; Max E Gottesman; Enrico V Avvedimento
Journal:  Cell Signal       Date:  2005-03       Impact factor: 4.315

2.  Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis.

Authors:  Isabelle Vergne; Jennifer Chua; Hwang-Ho Lee; Megan Lucas; John Belisle; Vojo Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 3.  Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections.

Authors:  Manira Rayamajhi; Jessica Humann; Staci Kearney; Krista K Hill; Laurel L Lenz
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

4.  Cyclic dinucleotides bind the C-linker of HCN4 to control channel cAMP responsiveness.

Authors:  Marco Lolicato; Annalisa Bucchi; Cristina Arrigoni; Stefano Zucca; Marco Nardini; Indra Schroeder; Katie Simmons; Marco Aquila; Dario DiFrancesco; Martino Bolognesi; Frank Schwede; Dmitry Kashin; Colin W G Fishwick; A Peter Johnson; Gerhard Thiel; Anna Moroni
Journal:  Nat Chem Biol       Date:  2014-04-28       Impact factor: 15.040

Review 5.  Cyclic di-GMP: the first 25 years of a universal bacterial second messenger.

Authors:  Ute Römling; Michael Y Galperin; Mark Gomelsky
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

6.  Structural basis of ligand binding by a c-di-GMP riboswitch.

Authors:  Kathryn D Smith; Sarah V Lipchock; Tyler D Ames; Jimin Wang; Ronald R Breaker; Scott A Strobel
Journal:  Nat Struct Mol Biol       Date:  2009-11-08       Impact factor: 15.369

Review 7.  DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison.

Authors:  Stefan Ehlers
Journal:  Eur J Cell Biol       Date:  2009-11-04       Impact factor: 4.492

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response.

Authors:  Kislay Parvatiyar; Zhiqiang Zhang; Rosane M Teles; Songying Ouyang; Yan Jiang; Shankar S Iyer; Shivam A Zaver; Mirjam Schenk; Shang Zeng; Wenwan Zhong; Zhi-Jie Liu; Robert L Modlin; Yong-jun Liu; Genhong Cheng
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

Review 10.  Cyclic di-AMP: another second messenger enters the fray.

Authors:  Rebecca M Corrigan; Angelika Gründling
Journal:  Nat Rev Microbiol       Date:  2013-07-01       Impact factor: 60.633

View more
  33 in total

Review 1.  Macrophage: A Cell With Many Faces and Functions in Tuberculosis.

Authors:  Faraz Ahmad; Anshu Rani; Anwar Alam; Sheeba Zarin; Saurabh Pandey; Hina Singh; Seyed Ehtesham Hasnain; Nasreen Zafar Ehtesham
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

2.  Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Authors:  Laetitia Petit-Jentreau; Grégory Jouvion; Patricia Charles; Laleh Majlessi; Brigitte Gicquel; Ludovic Tailleux
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

3.  Structural and Biochemical Insight into the Mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP Phosphodiesterase.

Authors:  Qing He; Feng Wang; Shiheng Liu; Deyu Zhu; Hengjiang Cong; Fei Gao; Bingqing Li; Hongwei Wang; Zong Lin; Jun Liao; Lichuan Gu
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

4.  A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis.

Authors:  Bappaditya Dey; Ruchi Jain Dey; Laurene S Cheung; Supriya Pokkali; Haidan Guo; Jong-Hee Lee; William R Bishai
Journal:  Nat Med       Date:  2015-03-02       Impact factor: 53.440

5.  The FBPase Encoding Gene glpX Is Required for Gluconeogenesis, Bacterial Proliferation and Division In Vivo of Mycobacterium marinum.

Authors:  Jingfeng Tong; Lu Meng; Xinwei Wang; Lixia Liu; Liangdong Lyu; Chuan Wang; Yang Li; Qian Gao; Chen Yang; Chen Niu
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

6.  Eukaryotic-Type Ser/Thr Protein Kinase Mediated Phosphorylation of Mycobacterial Phosphodiesterase Affects its Localization to the Cell Wall.

Authors:  Neha Malhotra; Pradip K Chakraborti
Journal:  Front Microbiol       Date:  2016-02-09       Impact factor: 5.640

7.  Low-Density Granulocytes Are Elevated in Mycobacterial Infection and Associated with the Severity of Tuberculosis.

Authors:  Yating Deng; Jianqing Ye; Qing Luo; Zhikun Huang; Yiping Peng; Guoliang Xiong; Yang Guo; Hong Jiang; Junming Li
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

8.  The Small Breathing Amplitude at the Upper Lobes Favors the Attraction of Polymorphonuclear Neutrophils to Mycobacterium tuberculosis Lesions and Helps to Understand the Evolution toward Active Disease in An Individual-Based Model.

Authors:  Pere-Joan Cardona; Clara Prats
Journal:  Front Microbiol       Date:  2016-03-29       Impact factor: 5.640

Review 9.  Immunometabolism in Tuberculosis.

Authors:  Lanbo Shi; Eliseo A Eugenin; Selvakumar Subbian
Journal:  Front Immunol       Date:  2016-04-21       Impact factor: 7.561

10.  The Characterization of Escherichia coli CpdB as a Recombinant Protein Reveals that, besides Having the Expected 3´-Nucleotidase and 2´,3´-Cyclic Mononucleotide Phosphodiesterase Activities, It Is Also Active as Cyclic Dinucleotide Phosphodiesterase.

Authors:  Iralis López-Villamizar; Alicia Cabezas; Rosa María Pinto; José Canales; João Meireles Ribeiro; José Carlos Cameselle; María Jesús Costas
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.